News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NovaBay Pharmaceuticals, Inc. (NBY) To Present At The Annual Dialysis Conference In Atlanta


2/7/2014 9:22:24 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EMERYVILLE, Calif., Feb. 7, 2014 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biopharmaceutical company developing topical non-antibiotic anti-microbial products, today announced that NovaBay will have a booth at the Annual Dialysis Conference, held February 8-11, 2014 in Atlanta, GA. Dr. Allan G. Kavalich, a nephrologist based in San Bernardino, CA will be present in the NovaBay booth and available to answer questions on the research he conducted with NeutroPhase®* in 2013. NeutroPhase is a 0.01% pure hypochlorous acid in saline with no bleach impurities, unlike Dakin and other Dakin-like solutions. In laboratory testing NeutroPhase has been shown to be 100-fold more antimicrobial than Dakin and 100-fold safer than Dakin.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES